Form 4: ICU Medical CIO Converts RSUs, Sells for Tax

ICU Medical's Chief Information Officer, Ben Sousa, converted 1,300 Restricted Stock Units into common stock and subsequently sold 718 shares to cover tax obligations on March 15, 2026.

Summary

• Ben Sousa, Chief Information Officer of ICU Medical Inc./DE (ICUI), reported transactions involving the company's common stock.
• On March 15, 2026, Sousa acquired 1,300 shares of common stock through the conversion of Restricted Stock Units (RSUs) at a price of $0.0 per share.
• Immediately following the acquisition, Sousa disposed of 718 shares of common stock at a price of $125.85 per share.
• The disposition of shares was for the payment of tax liability related to the RSU conversion.
• After these transactions, Sousa directly beneficially owns 5,326 shares of ICU Medical common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine insider filing related to the vesting of equity compensation and subsequent tax withholding, which does not typically indicate a change in the company's fundamental outlook or the insider's confidence.

Positives

• The conversion of 1,300 Restricted Stock Units indicates the vesting of equity compensation for the Chief Information Officer, reflecting continued tenure and performance.

Negatives

• A total of 718 shares were sold, reducing the direct beneficial ownership of the Chief Information Officer, although this was for tax purposes related to RSU vesting.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to the vesting and tax-related sale of Restricted Stock Units, are common occurrences in publicly traded companies across all industries. These transactions typically reflect compensation structures rather than a change in strategic outlook or operational performance, distinguishing them from discretionary open-market purchases or sales that might signal management's confidence or concern.

Comparison to Industry Standards

• The RSU conversion and subsequent tax-related sale by an executive at ICU Medical are standard practices for equity compensation in the healthcare technology and medical device sectors. Companies like Medtronic (MDT), Baxter International (BAX), and Becton, Dickinson and Company (BDX) frequently report similar Form 4 filings for their executives as equity awards vest and tax obligations are met. This transaction aligns with typical executive compensation and tax planning strategies observed across comparable industry peers.

Stakeholder Impact

• Shareholders: The sale of 718 shares by a key executive, while for tax purposes, represents a minor reduction in insider ownership. This is generally not considered a significant indicator for long-term investors.
• Employees: The vesting of RSUs for an executive reinforces the company's compensation structure, which may positively influence employee morale regarding equity incentives.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the conversion of Restricted Stock Units and a subsequent sale of shares to cover tax obligations. Such transactions are common for executives receiving equity compensation and do not typically reflect a change in the company's operational performance or strategic direction. Therefore, this filing alone does not provide sufficient new information to warrant a change from a 'hold' recommendation.

Keywords

ICU Medical, ICUI, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Stock Sale, Chief Information Officer, Ben Sousa